ISIN | CH0118503355 |
---|---|
Valor Number | 11850335 |
Bloomberg Global ID | |
Fund Name | Equity Switzerland Optimized ESG IR |
Fund Provider |
UBS Fund Management (Switzerland) AG
Basel, Switzerland Phone: +41 61 288 75 01 E-Mail: sh-ubs-funds-feedback@ubs.com Web: www.ubs.com/fonds |
Fund Provider | UBS Fund Management (Switzerland) AG |
Representative in Switzerland | |
Distributor(s) |
UBS AG Basel Phone: +41 61 288 75 01 |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Accumulation |
Home Country | Switzerland |
Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | The fund offers investors in Swiss equities an efficient alternative to traditional index weighting. Taking account of the limited marketability of most Swiss equities, an optimally diversified portfolio is compiled as part of a systematic, disciplined investment process; this portfolio improves the risk-return ratio of the SPI. |
Peculiarities |
Current Price * | 2,535.39 CHF | 14.11.2024 |
---|---|---|
Previous Price * | 2,525.22 CHF | 13.11.2024 |
52 Week High * | 2,686.70 CHF | 02.09.2024 |
52 Week Low * | 2,366.76 CHF | 16.11.2023 |
NAV * | 2,535.39 CHF | 14.11.2024 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 255,860,908 | |
Unit/Share Assets *** | 255,860,908 | |
Trading Information SIX |
YTD Performance | +4.30% |
29.12.2023 - 14.11.2024
29.12.2023 14.11.2024 |
---|---|---|
1 month | -5.19% |
14.10.2024 - 14.11.2024
14.10.2024 14.11.2024 |
3 months | -3.50% |
14.08.2024 - 14.11.2024
14.08.2024 14.11.2024 |
6 months | -0.55% |
14.05.2024 - 14.11.2024
14.05.2024 14.11.2024 |
1 year | +6.54% |
14.11.2023 - 14.11.2024
14.11.2023 14.11.2024 |
2 years | +8.84% |
14.11.2022 - 14.11.2024
14.11.2022 14.11.2024 |
3 years | -9.69% |
15.11.2021 - 14.11.2024
15.11.2021 14.11.2024 |
5 years | +13.21% |
28.02.2020 - 14.11.2024
28.02.2020 14.11.2024 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Novartis AG Registered Shares | 8.49% | |
---|---|---|
Nestle SA | 7.48% | |
Roche Holding AG | 4.89% | |
Barry Callebaut AG | 4.56% | |
PSP Swiss Property AG | 4.47% | |
Galenica Ltd | 4.08% | |
Chocoladefabriken Lindt & Spruengli AG | 4.03% | |
Swisscom AG | 4.02% | |
Givaudan SA | 3.99% | |
Swiss Prime Site AG | 3.96% | |
Last data update | 30.04.2024 |
TER | 0.66% |
---|---|
TER date | 31.08.2023 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.60% |
Ongoing Charges *** | 0.68% |
SRRI ***
|
|
SRRI date *** | 31.10.2024 |
Low Carbon Designation *** | |
---|---|
ESG Rating Overall *** | |
ESG Rating Corporate *** | |
ESG Rating Sovereign *** | |
% AuM H&S Controversies *** |
Avg Carbon Risk Score *** | |
---|---|
Avg Carbon Risk Cat Avg *** | |
% AuM Covered Carbon *** | |
Avg Fossil Fuel Exposure *** | |
Fossil Fuel Cat Avg *** |
Strategy Level 1 *** | |
---|---|
Strategy Level 2 *** | |
Strategy Level 3 *** | |
Exclusions Level 1 *** | |
Exclusions Level 2 *** |